Patent classifications
C07D517/04
COMPOUNDS, INFRARED ABSORBERS, INFRARED ABSORBING/BLOCKING FILMS, PHOTOELECTRIC DEVICES, SENSORS, AND ELECTRONIC DEVICES
A compound is represented by Chemical Formula 1.
##STR00001##
In Chemical Formula 1, R.sup.1 to R.sup.4, R.sup.11a to R.sup.14c, and n are the same as defined in the detailed description.
COMPOUNDS, INFRARED ABSORBERS, INFRARED ABSORBING/BLOCKING FILMS, PHOTOELECTRIC DEVICES, SENSORS, AND ELECTRONIC DEVICES
A compound is represented by Chemical Formula 1.
##STR00001##
In Chemical Formula 1, R.sup.1 to R.sup.4, R.sup.11a to R.sup.14c, and n are the same as defined in the detailed description.
SYNTHETIC METHOD OF FUSED HETEROAROMATIC COMPOUND AND FUSED HETEROAROMATIC COMPOUND, AND INTERMEDIATE THEREOF
A method of synthesizing a fused heteroaromatic compound includes obtaining a first intermediate from a first compound represented by Chemical Formula 1 and a second compound represented by Chemical Formula 2, obtaining a second intermediate including a ring having a chalcogen element from the first intermediate, and obtaining a fused heteroaromatic compound by a cyclization reaction of the second intermediate.
ELECTROACTIVE MATERIALS
There is disclosed a compound having Formula I, Formula II, Formula III, Formula VIII, Formula IX, or Formula X
##STR00001##
The variables are described in detail in the application.
SELENOPHENOCHROMENE HYDROXAMIC ACIDS, PREPARATION AND USE AS ANGIOGENESIS INHIBITORS
The present invention relates to a novel selenophenochromene hydroxamic acids as angiogenesis inhibitors, as well as methods of their manufacturing and use in different pharmaceutical compositions for the treatment or prevention of various diseases and disorders by administration of such substances.
SELENOPHENOCHROMENE HYDROXAMIC ACIDS, PREPARATION AND USE AS ANGIOGENESIS INHIBITORS
The present invention relates to a novel selenophenochromene hydroxamic acids as angiogenesis inhibitors, as well as methods of their manufacturing and use in different pharmaceutical compositions for the treatment or prevention of various diseases and disorders by administration of such substances.
ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE
There is provided an organic compound represented by formula [1-1] or [1-2]:
##STR00001##
where R.sub.1 to R.sub.20 are each independently selected from a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, an amino group, an aromatic hydrocarbon group, a heterocyclic group, an aryloxy group, a silyl group, and a cyano group, in which at least one of R.sub.1 to R.sub.4 and R.sub.6 to R.sub.9 and at least one of R.sub.11 to R.sub.14 and R.sub.16 to R.sub.19 are amino groups; and X.sub.1 to X.sub.4 are each oxygen, sulfur, selenium, or tellurium and are optionally the same or different.
BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR
Hallucinogenic and non-hallucinogenic serotonin receptor agonists are disclosed herein in addition to methods of making and using the same.
Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor
Hallucinogenic and non-hallucinogenic serotonin receptor agonists are disclosed herein in addition to methods of making and using the same.
INFRARED ABSORBERS, INFRARED ABSORBING/BLOCKING FILMS AND PHOTOELECTRIC DEVICES AND ORGANIC SENSORS AND ELECTRONIC DEVICES
An infrared absorber includes a compound represented by Chemical Formula 1. An infrared absorbing/blocking film, a photoelectric device, an organic sensor, and an electronic device may include the infrared absorber.
##STR00001##
In Chemical Formula 1, Ar, X.sup.1, X.sup.2, Y.sup.1, Y.sup.2, R.sup.1, R.sup.2, R.sup.11, R.sup.12, R.sup.13, and R.sup.14 are the same as defined in the detailed description.